Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates

Journal of Virology

Volumn 72, Issue 9, 1998, Pages 7201-7212

  Holtappels, Rafaela ^a   Podlech, Jürgen ^a   Geginat, Gernot ^b   Steffens, Hans Peter ^a   Thomas, Doris ^a   Reddehase, Matthias J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; LUNG INFECTION; LUNG INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS PNEUMONIA;

EID: 0031870165     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.9.7201-7212.1998     Document Type: Article

References (60)

1. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G, McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotype analysis of antigen-specific T lymphocytes. Science (Washington, D.C.) 274:94-96.
2. Azuma, M., M. Cayabyab, D. Buck, J. H. Philipps, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353-360.
3. Azuma, M., M. Cayabyab, J. H. Phillips, and L. L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150: 2091-2101.
4. Bancroft, G. J., G. R. Shellam, and J. E. Chalmer. 1981. Genetic influence on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126: 988-994.
5. Bukowski, J. F., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119-128.
6. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395-1402.
7. Carding, S. R., W. Allan, S. Kyes, A. Hayday, K. Bottomly, and P. C. Doherty. 1990. Late dominance of the inflammatory process in murine influenza by γδ T cells. J. Exp. Med. 172:1225-1231.
8. Christinck, E. R., M. A. Luscher, B. H. Barber, and D. B. Williams. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (London) 352:67-70.
9. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (London) 312:252-254.
10. Del Val, M., H. Hengel, H. Häcker, U. Hartlaub, T. Ruppert, P. Lucin, and U. H. Koszinowski. 1992. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176:729-738.
11. Del Val, M., K. Münch, M. J. Reddehase, and U. H. Koszinowski. 1989. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 58:305-315.
12. Del Val, M., H.-J. Schlicht, H. Volkmer, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 1991. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:3641-3646.
13. Del Val, M., H. Volkmer, J. B. Rothbard, S. Jonjic, M. Messerle, J. Schickedanz, M. J. Reddehase, and U. H. Koszinowski. 1988. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 62:3965-3972.
14. Farrell, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature (London) 386:510-514.
15. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Plückthun, T. Elliot, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383-1393.
16. Geginat, G., T. Ruppert, H. Hengel, R. Holtappels, and U. H. Koszinowski. 1997. IFN-γ is a prerequisite for optimal antigen processing of viral peptides in vivo. J. Immunol. 158:3303-3310.
17. Gilbert, M. J., S. R. Riddell, B. Plachter, and P. D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature (London) 383:720-722.
18. Harnett, G. B., and G. R. Shellam. 1982. Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance. J. Gen. Virol. 62:39-47.
19. Hengel, H., and U. H. Koszinowski. 1997. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9:470-476.
20. Hengel, H., P. Lucin, S. Jonjic, T. Ruppert, and U. H. Koszinowski. 1994. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289-297.
21. Ho, M. 1995. Cytomegaloviruses, p. 1351-1364. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
22. Höglund, P., J. Sundbäck, M. Y. Olsson-Alheim, M. Johansson, M. Salcedo, C. Öhlen, H.-G. Ljunggren, C. L. Sentman, and K. Kärre. 1997. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155: 11-28.
23. Holt, P. G., A. Degebrodt, T. Venaille, C. O'Leary, K. Krska, J. Flexman, H. Farrell, G. Shellam, P. Young, J. Penhale, T. Robertson, and J. M. Papadimitriou. 1985. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 54:139-147.
24. Jones, M., J. L. Cordell, A. D. Beyers, A. G. D. Tse, and D. Y. Mason. 1993. Detection of T and B cells in many animal species using cross-reactive anti-peptidc antibodies. J. Immunol. 150:5429-5435.
25. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perform-and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156:3678-3686.
26. Koszinowski, U. H., M. del Val, and M. J. Reddehase. 1990. Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 154:189-220.
27. Koszinowski, U. H., M. J. Reddehase, and S. Jonjic. 1993. The role of T-lymphocyte subsets in the control of cytomegalovirus infection, p. 429-445. In D. B. Thomas (ed.), Viruses and the cellular immune response. Marcel Dekker, Inc., New York, N.Y.
28. Kranz, D. M., S. Tonegawa, and H. N. Eisen. 1984. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 81:7922-7926.
29. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145-154.
30. Lanier, L. L., H. Spits, and J. H. Philipps. 1992. The developmental relationship between NK cells and T cells. Immunol. Today 13:392-395.
31. Lathbury, L. J., J. E. Allan, G. R. Shellam, and A. A. Scalzo. 1996. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J. Gen. Virol. 77:2605-2613.
32. Mayer, A., J. Podlech, S. Kurz, H.-P. Steffens, S. Maiberger, K. Thalmeier, P. Angele, L. Dreher, and M. J. Reddehase. 1997. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J. Virol. 71:4589-4598.
33. McMichael, A. J., and C. A. O'Callaghan. 1998. A new look at T cells. J. Exp. Med. 187:1367-1371.
34. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
35. Mutter, W., M. J. Reddehase, F. W. Busch, H.-J. Bühring, and U. H. Koszinowski. 1988. Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J. Exp. Med. 167:1645-1658.
36. Podlech, J., R. Holtappels, N. Wirtz, H.-J. Steffens, and M. J. Reddehase. 1998. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation. J. Gen. Virol. 79:2099-2104.
37. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
38. Reddehase, M. J., H.-J. Bühring, and U. H. Koszinowski. 1986. Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus. J. Virol. 57:408-412.
39. Reddehase, M. J., M. R. Fibi, G. M. Keil, and U. H. Koszinowski. 1986. Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J. Virol. 60:1125-1129.
40. Reddehase, M. J., G. M. Keil, and U. H. Koszinowski. 1984. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J. Immunol. 132:482-489.
41. Reddehase, M. J., G. M. Keil, and U. H. Koszinowski. 1984. The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur. J. Immunol. 14:56-61.
42. Reddehase, M. J., and U. H. Koszinowski. 1984. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature (London) 312:369-371.
43. Reddehase, M. J., W. Mutter, K. Münch, H.-J. Bühring, and U. H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61: 3102-3108.
44. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature (London) 337:651-653.
45. Reddehase, M. J., F. Weiland, K. Münch, S. Jonjic, A. Lüske, and U. H. Koszinowski. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
46. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
47. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature (London) 386:514-517.
48. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science (Washington, D.C.) 257:238-241.
49. Rötzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (London) 348:252-254.
50. Rötzschke, O., K. Falk, H.-J. Wallny, S. Faath, and H.-G. Rammensee. 1990. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science (Washington, D.C.) 249:283-287.
51. Scalzo, A. A., N. A. Fitzgerald, A. Simmons, A. B. LaVista, and G. R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469-1483.
52. Shanley, J. D., and E. L. Pesanti. 1985. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection J Infect. Dis. 151:454-458.
53. Spits, H., H. Yssel, J. Leeuwenberg, and J. E. de Vries. 1985. Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur. J. Immunol. 15:88-91.
54. Steffens, H.-P., S. Kurz, R. Holtappels, and M. J. Reddehase. 1998. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J. Virol. 72:1797-1804.
55. Steffens, H.-P., J. Podlech, S. Kurz, P. Angele, D. Dreis, and M. J. Reddehase. 1998. Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72:5006-5015.
56. Thäle, R., U. Szepan, H. Hengel, G. Geginat, P. Lucin, and U. H. Koszinowski. 1995. Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J. Virol. 69:6098-6105.
57. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I Interferon in vivo. Science (Washington, D.C.) 272:1947-1950.
58. Winston, D. J., W. G. Ho, and R. E. Champlin. 1990. Cytomegalovirus infections after bone marrow transplantation. Rev. Infect. Dis. 12:S776-S792.
59. Zheng, P., and Y. Liu. 1997. Costimulation by B7 modulates specificity of cytotoxic T lymphocytes: a missing link that explains some bystander T cell activation. J. Exp. Med. 186:1787-1791.
60. Ziegler, H., R. Thäle, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farell, W. Rawlinson, and U. H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57-66.